Overview

Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Status:
NOT_YET_RECRUITING

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

Summary

This study aims to evaluate the efficacy and safety of Mavacamten combined with radiofrequency ablation compared to Mavacamten alone in patients with symptomatic obstructive hypertrophic cardiomyopathy (HOCM). Participants were randomized into two groups:

Phase:

Details

Lead Sponsor:

Shanghai Chest Hospital

Treatments:

MYK-461
Radiofrequency Ablation